Product Information
QC ADULT TUSSIN CF LIQUID is a generic product labeled by Chain Drug Marketing Association, priced at $0.0209 per ML under NDC 83324015504. Its NADAC has been published 87 times since Feb 5, 2025.
Strength
20; 200; 10 mg/10mL; mg/10mL; mg/10mL
Manufacturer
Chain Drug Marketing AssociationNDC
83324015504
Classification
Generic
Dosage Form
LIQUID
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
7/31/2024
Pharmacological Classes
Price Statistics
The NADAC for QC ADULT TUSSIN CF LIQUID has been published 87 times since Feb 5, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0209 per ML |
|---|---|
| All-time high | $0.0212 (Feb 12, 2025) |
| All-time low | $0.0192 (Jul 23, 2025) |
| 52-week high | $0.0210 |
| 52-week low | $0.0193 |
| Median price | $0.0206 |
| Average price | $0.0202 |
| Largest weekly change | -3.3% (May 21, 2025) |
| Weeks tracked | 87 |
| Tracking since | Feb 5, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dextromethorphan HBr Guaifenesin Phenylephrine HCl market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chain Drug Marketing Association manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dextromethorphan HBr Guaifenesin Phenylephrine HCl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QC ADULT TUSSIN CF LIQUID?
The current National Average Drug Acquisition Cost (NADAC) for QC ADULT TUSSIN CF LIQUID, manufactured by Chain Drug Marketing Association, is $0.0209 per ML (NDC 83324015504), effective Sep 30, 2026.
How has the price of QC ADULT TUSSIN CF LIQUID changed over time?
Over the history we have for it, the NADAC for QC ADULT TUSSIN CF LIQUID has held within roughly two percent of its current level. It has been tracked across 87 weekly CMS publications since Feb 5, 2025.
What are the highest and lowest recorded NADAC prices for QC ADULT TUSSIN CF LIQUID?
Since Feb 5, 2025, the NADAC for QC ADULT TUSSIN CF LIQUID has ranged from a low of $0.0192 (Jul 23, 2025) to a high of $0.0212 (Feb 12, 2025), with a median of $0.0206 per ML.
Are there cheaper alternatives to QC ADULT TUSSIN CF LIQUID?
No other NADAC-published product currently shares the active ingredient and strength of QC ADULT TUSSIN CF LIQUID in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures QC ADULT TUSSIN CF LIQUID?
QC ADULT TUSSIN CF LIQUID (NDC 83324015504) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.